Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Human Somatotropin, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Human Somatotropin Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Human Somatotropin Manufacturers Covered: Ranking by Revenue
  • 1.4 Market 2
    • 1.4.1 Global Human Somatotropin Market Size Growth Rate 2
    • 1.4.2 Powder
    • 1.4.3 Solvent
  • 1.5 Market 7
    • 1.5.1 Global Human Somatotropin Market Size Growth Rate 7
    • 1.5.2 Growth Hormone Deficiency (GHD)
    • 1.5.3 Turner Syndrome
    • 1.5.4 Chronic Renal Insufficiency
    • 1.5.5 Prader Willi Syndrome
    • 1.5.6 Small for Gestational Age
    • 1.5.7 SHOX Deficiency
    • 1.5.8 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Human Somatotropin Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Human Somatotropin Industry
      • 1.6.1.1 Human Somatotropin Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Human Somatotropin Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Human Somatotropin Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Human Somatotropin Market Size Estimates and Forecasts
    • 2.1.1 Global Human Somatotropin Revenue 2015-2026
    • 2.1.2 Global Human Somatotropin Sales 2015-2026
  • 2.2 Human Somatotropin Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Human Somatotropin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Human Somatotropin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Human Somatotropin Competitor Landscape by Players

  • 3.1 Human Somatotropin Sales by Manufacturers
    • 3.1.1 Human Somatotropin Sales by Manufacturers (2015-2020)
    • 3.1.2 Human Somatotropin Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Human Somatotropin Revenue by Manufacturers
    • 3.2.1 Human Somatotropin Revenue by Manufacturers (2015-2020)
    • 3.2.2 Human Somatotropin Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Human Somatotropin Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Human Somatotropin Revenue in 2019
    • 3.2.5 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Human Somatotropin Price by Manufacturers
  • 3.4 Human Somatotropin Manufacturing Base Distribution, Product Types
    • 3.4.1 Human Somatotropin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Human Somatotropin Product Type
    • 3.4.3 Date of International Manufacturers Enter into Human Somatotropin Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data 2 (2015-2026)

  • 4.1 Global Human Somatotropin Market Size 2 (2015-2020)
    • 4.1.1 Global Human Somatotropin Sales 2 (2015-2020)
    • 4.1.2 Global Human Somatotropin Revenue 2 (2015-2020)
    • 4.1.3 Human Somatotropin Average Selling Price (ASP) 2 (2015-2026)
  • 4.2 Global Human Somatotropin Market Size Forecast 2 (2021-2026)
    • 4.2.1 Global Human Somatotropin Sales Forecast 2 (2021-2026)
    • 4.2.2 Global Human Somatotropin Revenue Forecast 2 (2021-2026)
    • 4.2.3 Human Somatotropin Average Selling Price (ASP) Forecast 2 (2021-2026)
  • 4.3 Global Human Somatotropin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data 7 (2015-2026)

  • 5.1 Global Human Somatotropin Market Size 7 (2015-2020)
    • 5.1.1 Global Human Somatotropin Sales 7 (2015-2020)
    • 5.1.2 Global Human Somatotropin Revenue 7 (2015-2020)
    • 5.1.3 Human Somatotropin Price 7 (2015-2020)
  • 5.2 Human Somatotropin Market Size Forecast 7 (2021-2026)
    • 5.2.1 Global Human Somatotropin Sales Forecast 7 (2021-2026)
    • 5.2.2 Global Human Somatotropin Revenue Forecast 7 (2021-2026)
    • 5.2.3 Global Human Somatotropin Price Forecast 7 (2021-2026)

6 North America

  • 6.1 North America Human Somatotropin by Country
    • 6.1.1 North America Human Somatotropin Sales by Country
    • 6.1.2 North America Human Somatotropin Revenue by Country
    • 6.1.3 United States
    • 6.1.4 Canada
    • 6.1.5 Mexico
  • 6.2 North America Human Somatotropin Market Facts & Figures 2
  • 6.3 North America Human Somatotropin Market Facts & Figures 7

7 Europe

  • 7.1 Europe Human Somatotropin by Country
    • 7.1.1 Europe Human Somatotropin Sales by Country
    • 7.1.2 Europe Human Somatotropin Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 UK
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Human Somatotropin Market Facts & Figures 2
  • 7.3 Europe Human Somatotropin Market Facts & Figures 7

8 Asia Pacific

  • 8.1 Asia Pacific Human Somatotropin by Region
    • 8.1.1 Asia Pacific Human Somatotropin Sales by Region
    • 8.1.2 Asia Pacific Human Somatotropin Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Indonesia
    • 8.1.9 Thailand
    • 8.1.10 Malaysia
    • 8.1.11 Philippines
    • 8.1.12 Vietnam
  • 8.2 Asia Pacific Human Somatotropin Market Facts & Figures 2
  • 8.3 Asia Pacific Human Somatotropin Market Facts & Figures 7

9 Latin America

  • 9.1 Latin America Human Somatotropin by Country
    • 9.1.1 Latin America Human Somatotropin Sales by Country
    • 9.1.2 Latin America Human Somatotropin Revenue by Country
    • 9.1.3 Brazil
  • 9.2 Central & South America Human Somatotropin Market Facts & Figures 2
  • 9.3 Central & South America Human Somatotropin Market Facts & Figures 7

10 Middle East and Africa

  • 10.1 Middle East and Africa Human Somatotropin by Country
    • 10.1.1 Middle East and Africa Human Somatotropin Sales by Country
    • 10.1.2 Middle East and Africa Human Somatotropin Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 GCC Countries
    • 10.1.5 Egypt
    • 10.1.6 South Africa
  • 10.2 Middle East and Africa Human Somatotropin Market Facts & Figures 2
  • 10.3 Middle East and Africa Human Somatotropin Market Facts & Figures 7

11 Company Profiles

  • 11.1 Novo Nordisk
    • 11.1.1 Novo Nordisk Corporation Information
    • 11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
    • 11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novo Nordisk Human Somatotropin Products Offered
    • 11.1.5 Novo Nordisk Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description, Business Overview and Total Revenue
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Human Somatotropin Products Offered
    • 11.2.5 Pfizer Recent Development
  • 11.3 Eli Lilly
    • 11.3.1 Eli Lilly Corporation Information
    • 11.3.2 Eli Lilly Description, Business Overview and Total Revenue
    • 11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Eli Lilly Human Somatotropin Products Offered
    • 11.3.5 Eli Lilly Recent Development
  • 11.4 Merck Serono
    • 11.4.1 Merck Serono Corporation Information
    • 11.4.2 Merck Serono Description, Business Overview and Total Revenue
    • 11.4.3 Merck Serono Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Merck Serono Human Somatotropin Products Offered
    • 11.4.5 Merck Serono Recent Development
  • 11.5 F. Hoffmann-La Roche
    • 11.5.1 F. Hoffmann-La Roche Corporation Information
    • 11.5.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
    • 11.5.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 F. Hoffmann-La Roche Human Somatotropin Products Offered
    • 11.5.5 F. Hoffmann-La Roche Recent Development
  • 11.6 Ferring Pharmaceuticals
    • 11.6.1 Ferring Pharmaceuticals Corporation Information
    • 11.6.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.6.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Ferring Pharmaceuticals Human Somatotropin Products Offered
    • 11.6.5 Ferring Pharmaceuticals Recent Development
  • 11.7 GeneScience Pharmaceuticals
    • 11.7.1 GeneScience Pharmaceuticals Corporation Information
    • 11.7.2 GeneScience Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.7.3 GeneScience Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 GeneScience Pharmaceuticals Human Somatotropin Products Offered
    • 11.7.5 GeneScience Pharmaceuticals Recent Development
  • 11.8 Ipsen
    • 11.8.1 Ipsen Corporation Information
    • 11.8.2 Ipsen Description, Business Overview and Total Revenue
    • 11.8.3 Ipsen Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Ipsen Human Somatotropin Products Offered
    • 11.8.5 Ipsen Recent Development
  • 11.9 LG Life Sciences
    • 11.9.1 LG Life Sciences Corporation Information
    • 11.9.2 LG Life Sciences Description, Business Overview and Total Revenue
    • 11.9.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 LG Life Sciences Human Somatotropin Products Offered
    • 11.9.5 LG Life Sciences Recent Development
  • 11.10 Sandoz International
    • 11.10.1 Sandoz International Corporation Information
    • 11.10.2 Sandoz International Description, Business Overview and Total Revenue
    • 11.10.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Sandoz International Human Somatotropin Products Offered
    • 11.10.5 Sandoz International Recent Development
  • 11.1 Novo Nordisk
    • 11.1.1 Novo Nordisk Corporation Information
    • 11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
    • 11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novo Nordisk Human Somatotropin Products Offered
    • 11.1.5 Novo Nordisk Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Human Somatotropin Market Estimates and Projections by Region
    • 12.1.1 Global Human Somatotropin Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Human Somatotropin Revenue Forecast by Regions 2021-2026
  • 12.2 North America Human Somatotropin Market Size Forecast (2021-2026)
    • 12.2.1 North America: Human Somatotropin Sales Forecast (2021-2026)
    • 12.2.2 North America: Human Somatotropin Revenue Forecast (2021-2026)
    • 12.2.3 North America: Human Somatotropin Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Human Somatotropin Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Human Somatotropin Sales Forecast (2021-2026)
    • 12.3.2 Europe: Human Somatotropin Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Human Somatotropin Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Human Somatotropin Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Human Somatotropin Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Human Somatotropin Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Human Somatotropin Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Human Somatotropin Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Human Somatotropin Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Human Somatotropin Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Human Somatotropin Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Human Somatotropin Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Human Somatotropin Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Human Somatotropin Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Human Somatotropin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Human Somatotropin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Human Somatotropin Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Human Somatotropin market is segmented 2, and 7. Players, stakeholders, and other participants in the global Human Somatotropin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast 2 and 7 for the period 2015-2026.

    Segment 2, the Human Somatotropin market is segmented into
    Powder
    Solvent

    Segment 7, the Human Somatotropin market is segmented into
    Growth Hormone Deficiency (GHD)
    Turner Syndrome
    Chronic Renal Insufficiency
    Prader Willi Syndrome
    Small for Gestational Age
    SHOX Deficiency
    Others

    Regional and Country-level Analysis
    The Human Somatotropin market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Human Somatotropin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Brazil, Turkey, GCC Countries, Egypt, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast 2, and 7 segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Human Somatotropin Market Share Analysis
    Human Somatotropin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Somatotropin business, the date to enter into the Human Somatotropin market, Human Somatotropin product introduction, recent developments, etc.
    The major vendors covered:
    Novo Nordisk
    Pfizer
    Eli Lilly
    Merck Serono
    F. Hoffmann-La Roche
    Ferring Pharmaceuticals
    GeneScience Pharmaceuticals
    Ipsen
    LG Life Sciences
    Sandoz International
    Anhui Anke Biotechnology

    Buy now